E-LIB Suche - Ergebnisse für: Daver, N. G.

1

Dorsal Column Myelopathy Following Intrathecal Chemotherapy..:

Schrank, B.R. ; Manzar, G.S. ; Wu, S.Y....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e486-e487 , 2023

Link: https://doi.org/10.1016/..

2

P562: LEMZOPARLIMAB (LEMZO) WITH VENETOCLAX (VEN) AND/OR AZ..:

Hou, J.-Z. ; Daver, N. G. ; Stevens, D. A....
HemaSphere. 6 (2022) - p. 461-462 , 2022

Link: https://doi.org/10.1097/..

3

S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-..:

Daver, N. G. ; Vyas, P. ; Kambhampati, S....
HemaSphere. 6 (2022) - p. 33-34 , 2022

Link: https://doi.org/10.1097/..

4

P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHE..:

Hasegawa, K. ; Wei, A. H. ; Garcia-Manero, G....
HemaSphere. 6 (2022) - p. 669-670 , 2022

Link: https://doi.org/10.1097/..

5

PB1849: TRIAL IN PROGRESS: PHASE IB/II STUDY OF SIREMADLIN ..:

Daver, N. G. ; Wei, A. H. ; Stein, E. M....
HemaSphere. 6 (2022) - p. 1729-1730 , 2022

Link: https://doi.org/10.1097/..

6

P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DR..:

Daver, N. G. ; Montesinos, P. ; Aribi, A....
HemaSphere. 6 (2022) - p. 454-455 , 2022

Link: https://doi.org/10.1097/..

7

P553: A PHASE 2, OPEN-LABEL, MULTIARM, MULTICENTER STUDY TO..:

Vyas, P. ; Daver, N. G. ; Chao, M. P....
HemaSphere. 6 (2022) - p. 452-453 , 2022

Link: https://doi.org/10.1097/..

8

P550: A PHASE 3, RANDOMIZED TRIAL OF MAGROLIMAB IN COMBINAT..:

Daver, N. G. ; Liu, K. ; Werneke, S....
HemaSphere. 6 (2022) - p. 449-450 , 2022

Link: https://doi.org/10.1097/..

9

P552: TREATMENT OUTCOMES IN NEWLY DIAGNOSED, UNTREATED PATI..:

Daver, N. G. ; Iqbal, S. ; Renard, C....
HemaSphere. 6 (2022) - p. 451-452 , 2022

Link: https://doi.org/10.1097/..

10

P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING TH..:

Daver, N. G. ; Vyas, P. ; Chao, M. P....
HemaSphere. 6 (2022) - p. 450-451 , 2022

Link: https://doi.org/10.1097/..

11

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMG..:

Pemmaraju, N. ; Martinelli, G. ; Todisco, E....
HemaSphere. 6 (2022) - p. 1708-1709 , 2022

Link: https://doi.org/10.1097/..

12

PB1922: EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER-RI..:

Rajakumaraswamy, N. ; Gandhi, M. ; Wei, A. H....
HemaSphere. 6 (2022) - p. 1801-1802 , 2022

Link: https://doi.org/10.1097/..

13

Overall responses and survival in RCC on pegilodecakin with..:

Naing, A. ; Infante, J.R. ; Wong, D.J....
European Journal of Cancer. 110 (2019) - p. S1-S2 , 2019

Link: https://doi.org/10.1016/..

14

Irradiated Extramedullary Acute Myeloid Leukemia Increases ..:

Saenz, F.R. ; Dabaja, B. ; Fang, G....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. S161 , 2023

Link: https://doi.org/10.1016/..

15

P566: IMPACT OF FRONTLINE INDUCTION APPROACH ON POST-STEM C..:

Ong, F. ; Ravandi, F. ; Popat, U....
HemaSphere. 6 (2022) - p. 465-466 , 2022

Link: https://doi.org/10.1097/..